drugset / Trial / NCT01723397

Effect of Nasaleze on Nasal Challenge With Allergen

NCT01723397 ↗

Terminated 14 enrolled University of Chicago
RandomizedCrossoverTriple-blindTreatment

Summary

The objectives of this protocol are: 1. to confirm the inhibitory effect of Nasaleze on the immediate response to nasal challenge with antigen, and 2. to show that inhibition of the immediate response to nasal challenge with antigen by Nasaleze inhibits subsequent inflammatory events.

Timeline

Start
2012-11
Primary completion
2014-07
Completion
2014-07

Outcome

Outcome not reported

Stopped (Enrollment): “Poor recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nasaleze Other / unclassified — Intranasal

Indications